Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies

Eduardo Anitua, Francisco Muruzabal, Ali Tayebba, Ana Riestra, Victor L Perez Quinones, Jesus Merayo-Lloves, Gorka Orive

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The use of blood derivatives represents an alternative therapeutic approach that is gaining interest in regenerative medicine due to its potential to stimulate and accelerate tissue healing. Autologous serum eye drops and platelet-enriched plasma eye drops are being used in the treatment of different ophthalmological disorders. In this review, we summarize the different blood-derived formulations used in the treatment and care of ocular surface disorders. The biological basis and use of autologous serum and plasma rich in growth factors are deeply evaluated as well as the challenges to be addressed in the future in this new generation of blood-derived therapies.

Original languageEnglish (US)
Pages (from-to)e605-e614
JournalActa Ophthalmologica
Volume93
Issue number8
DOIs
StatePublished - Dec 1 2015

Fingerprint

Ophthalmology
Intercellular Signaling Peptides and Proteins
Ophthalmic Solutions
Serum
Regenerative Medicine
Blood Platelets
Therapeutics
Clinical Studies

Keywords

  • autologous serum
  • cornea
  • dry eye
  • eye
  • ocular surface
  • plasma rich in growth factors
  • platelet-rich plasma

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Anitua, E., Muruzabal, F., Tayebba, A., Riestra, A., Perez Quinones, V. L., Merayo-Lloves, J., & Orive, G. (2015). Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies. Acta Ophthalmologica, 93(8), e605-e614. https://doi.org/10.1111/aos.12710

Autologous serum and plasma rich in growth factors in ophthalmology : Preclinical and clinical studies. / Anitua, Eduardo; Muruzabal, Francisco; Tayebba, Ali; Riestra, Ana; Perez Quinones, Victor L; Merayo-Lloves, Jesus; Orive, Gorka.

In: Acta Ophthalmologica, Vol. 93, No. 8, 01.12.2015, p. e605-e614.

Research output: Contribution to journalArticle

Anitua, E, Muruzabal, F, Tayebba, A, Riestra, A, Perez Quinones, VL, Merayo-Lloves, J & Orive, G 2015, 'Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies', Acta Ophthalmologica, vol. 93, no. 8, pp. e605-e614. https://doi.org/10.1111/aos.12710
Anitua E, Muruzabal F, Tayebba A, Riestra A, Perez Quinones VL, Merayo-Lloves J et al. Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies. Acta Ophthalmologica. 2015 Dec 1;93(8):e605-e614. https://doi.org/10.1111/aos.12710
Anitua, Eduardo ; Muruzabal, Francisco ; Tayebba, Ali ; Riestra, Ana ; Perez Quinones, Victor L ; Merayo-Lloves, Jesus ; Orive, Gorka. / Autologous serum and plasma rich in growth factors in ophthalmology : Preclinical and clinical studies. In: Acta Ophthalmologica. 2015 ; Vol. 93, No. 8. pp. e605-e614.
@article{426320eab9c840afa7af909d28b8fa01,
title = "Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies",
abstract = "The use of blood derivatives represents an alternative therapeutic approach that is gaining interest in regenerative medicine due to its potential to stimulate and accelerate tissue healing. Autologous serum eye drops and platelet-enriched plasma eye drops are being used in the treatment of different ophthalmological disorders. In this review, we summarize the different blood-derived formulations used in the treatment and care of ocular surface disorders. The biological basis and use of autologous serum and plasma rich in growth factors are deeply evaluated as well as the challenges to be addressed in the future in this new generation of blood-derived therapies.",
keywords = "autologous serum, cornea, dry eye, eye, ocular surface, plasma rich in growth factors, platelet-rich plasma",
author = "Eduardo Anitua and Francisco Muruzabal and Ali Tayebba and Ana Riestra and {Perez Quinones}, {Victor L} and Jesus Merayo-Lloves and Gorka Orive",
year = "2015",
month = "12",
day = "1",
doi = "10.1111/aos.12710",
language = "English (US)",
volume = "93",
pages = "e605--e614",
journal = "Acta Ophthalmologica",
issn = "1755-375X",
publisher = "Copenhagen Scriptor",
number = "8",

}

TY - JOUR

T1 - Autologous serum and plasma rich in growth factors in ophthalmology

T2 - Preclinical and clinical studies

AU - Anitua, Eduardo

AU - Muruzabal, Francisco

AU - Tayebba, Ali

AU - Riestra, Ana

AU - Perez Quinones, Victor L

AU - Merayo-Lloves, Jesus

AU - Orive, Gorka

PY - 2015/12/1

Y1 - 2015/12/1

N2 - The use of blood derivatives represents an alternative therapeutic approach that is gaining interest in regenerative medicine due to its potential to stimulate and accelerate tissue healing. Autologous serum eye drops and platelet-enriched plasma eye drops are being used in the treatment of different ophthalmological disorders. In this review, we summarize the different blood-derived formulations used in the treatment and care of ocular surface disorders. The biological basis and use of autologous serum and plasma rich in growth factors are deeply evaluated as well as the challenges to be addressed in the future in this new generation of blood-derived therapies.

AB - The use of blood derivatives represents an alternative therapeutic approach that is gaining interest in regenerative medicine due to its potential to stimulate and accelerate tissue healing. Autologous serum eye drops and platelet-enriched plasma eye drops are being used in the treatment of different ophthalmological disorders. In this review, we summarize the different blood-derived formulations used in the treatment and care of ocular surface disorders. The biological basis and use of autologous serum and plasma rich in growth factors are deeply evaluated as well as the challenges to be addressed in the future in this new generation of blood-derived therapies.

KW - autologous serum

KW - cornea

KW - dry eye

KW - eye

KW - ocular surface

KW - plasma rich in growth factors

KW - platelet-rich plasma

UR - http://www.scopus.com/inward/record.url?scp=84955723124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955723124&partnerID=8YFLogxK

U2 - 10.1111/aos.12710

DO - 10.1111/aos.12710

M3 - Article

C2 - 25832910

AN - SCOPUS:84955723124

VL - 93

SP - e605-e614

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-375X

IS - 8

ER -